Lonafarnib With and Without Ritonavir in HDV (LOWR-1)
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
To Evaluate the Safety and Efficacy of Lonafarnib with and without Ritonavir Boosting in
Adults With Genotype 1 Chronic Hepatitis D Virus (HDV) Infection (LOWR-1).